市場調査レポート

商品コード

1301102

臨床試験用品の市場規模、シェア、動向分析レポート：臨床フェーズ別、製品・サービス別、最終用途別、治療用途別、地域別、セグメント予測、2023年～2030年

Clinical Trial Supplies Market Size, Share & Trends Analysis Report By Clinical Phase (Phase I, Phase II, Phase III), By Product & Services, By End-Use, By Therapeutic Use, By Region, And Segment Forecasts, 2023 - 2030

出版日: 2023年06月21日 | 発行: Grand View Research

| ページ情報: 英文 123 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

Unprintable PDF (Single User License)

USD 5,950 926,772円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストはできません。PDFの印刷もできません。

Printable PDF (5-User License)

USD 6,950 1,082,532円

レポートPDFを同一企業内の同一部署における5名様までの方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

Printable PDF (Enterprise License)

USD 8,950 1,394,052円

レポートPDFの購入企業、およびその子会社、関連会社の方にご使用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=155.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

臨床試験用品市場の成長と動向

GrandView Research, Inc.の最新レポートによると、世界の臨床試験用品市場規模は2023年から2030年にかけてCAGR 6.5%で拡大し、2030年には34億米ドルに達する見込みです。

臨床試験量の増加と試験実施の複雑化は、市場成長を促進する主な要因の一つです。

世界的には、慢性疾患の有病率の増加と急速な高齢化が生物製剤の研究開発の成長を促進すると予想されており、効率的な臨床用品の需要をさらに促進し、臨床試験用品産業の成長に貢献すると期待されています。さらに、希少疾病用医薬品の需要の増加や希少疾病の研究開発への高い投資も、生物学的製剤の開発に貢献すると予想されます。このような要因から、このセグメントは予測期間中に大きな成長を遂げる可能性が高いです。

例えば、2022年にノバルティスは研究開発に約100億米ドルを投資しました。また、欧州連合（EU）、日本、中国、米国において、新薬と希少疾患について23件の承認を取得しています。また、インドでは44の進行中の第III相プログラムを実施しており、非定型溶血性尿毒症症候群（aHUS）、免疫性血小板減少性紫斑病（ITP）、脊髄性筋萎縮症（SMA）、ループス腎炎などの希少疾患では17の臨床プログラムを実施しています。

ダイレクト・ツー・ペイシェント（DTP）は、臨床試験用医薬品の流通において、今後の流通モデルとして期待されるセグメントです。DTPは新たなモデルの一つで、患者に直接薬剤を届け、患者中心の治験を行うものです。これにより、治験施設への訪問回数が減り、参加者の負担が軽減されます。COVID-19の発生は、最小限の混乱で臨床試験研究を継続するために、このようなモデルの採用を増加させることにつながっています。さらに、患者の維持と世界中の多様な患者プールは、このモデルの高い採用率に起因する顕著な理由の一部です。

臨床試験用品市場レポートハイライト

臨床フェーズに基づくと、2022年の売上高シェアはフェーズIII試験が52.7%を占め、市場を独占すると予測されます。現在第III相試験中の分子が多数存在することが、この減収の主な要因となっています。
サービスの中では、保管・流通分野が予測期間中CAGR 6.8%で最も急成長すると予測されています。世界の生物製剤パイプラインの増加と温度に敏感な医薬品の増加により、臨床試験用医薬品のロジスティクスに関する複雑さが増すと予想されます。
生物製剤は、ナノ粒子ベースのドラッグデリバリーシステムの開発など、遺伝学およびバイオテクノロジー分野の研究増加により、予測期間中にCAGR 6.7%で最速の成長が見込まれています。
治療用途では、腫瘍学が2022年の売上高シェア38.8%で市場を独占しています。United Press International別と、米国の病院では不適切な投与により何十億本もの抗がん剤バイアルが廃棄されており、適切な供給管理の必要性が指摘されています。

地域市場シェア分析、2022年および2030年
地域市場ダッシュボード
世界の地域市場のスナップショット
北米
- 市場推計・予測、2018年から2030年（収益）
- 米国
- カナダ
欧州
- 英国
- ドイツ
- フランス
- イタリア
- スペイン
- デンマーク
- スウェーデン
- ノルウェー
アジア太平洋地域
- 日本
- インド
- 中国
- 韓国
- オーストラリア
- タイ
ラテンアメリカ
- ブラジル
- メキシコ
- アルゼンチン
MEA
- 南アフリカ
- サウジアラビア
- アラブ首長国連邦
- クウェート

第9章競合情勢

市場参入企業の分類
- イノベーター
- マーケットリーダー
- 新興プレイヤー
- 企業の市場シェア分析、2022年
企業プロファイル
- Almac Group
- Biocair
- Catalent, Inc.
- KLIFO
- Movianto
- PCI Pharma Services
- Sharp Services, LLC
- Thermo Fisher Scientific, Inc.
- Marken
- Paraxel International Corporation

図表

List of Tables

Table 1 List of Abbreviations
Table 2 North America clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
Table 3 North America clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
Table 4 North America clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
Table 5 North America clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
Table 6 US clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
Table 7 US clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
Table 8 US clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
Table 9 US clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
Table 10 Canada clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
Table 11 Canada clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
Table 12 Canada clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
Table 13 Canada clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
Table 14 Europe clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
Table 15 Europe clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
Table 16 Europe clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
Table 17 Europe clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
Table 18 UK clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
Table 19 UK clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
Table 20 UK clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
Table 21 UK clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
Table 22 Germany clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
Table 23 Germany clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
Table 24 Germany clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
Table 25 Germany clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
Table 26 France clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
Table 27 France clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
Table 28 France clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
Table 29 France clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
Table 30 Italy clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
Table 31 Italy clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
Table 32 Italy clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
Table 33 Italy clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
Table 34 Spain clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
Table 35 Spain clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
Table 36 Spain clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
Table 37 Spain clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
Table 38 Denmark clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
Table 39 Denmark clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
Table 40 Denmark clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
Table 41 Denmark clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
Table 42 Sweden clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
Table 43 Sweden clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
Table 44 Sweden clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
Table 45 Sweden clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
Table 46 Norway clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
Table 47 Norway clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
Table 48 Norway clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
Table 49 Norway clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
Table 50 Asia Pacific clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
Table 51 Asia Pacific clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
Table 52 Asia Pacific clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
Table 53 Asia Pacific clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
Table 54 Japan clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
Table 55 Japan clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
Table 56 Japan clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
Table 57 Japan clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
Table 58 China clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
Table 59 China clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
Table 60 China clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
Table 61 China clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
Table 62 India clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
Table 63 India clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
Table 64 India clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
Table 65 India clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
Table 66 Australia clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
Table 67 Australia clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
Table 68 Australia clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
Table 69 Australia clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
Table 70 South Korea clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
Table 71 South Korea clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
Table 72 South Korea clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
Table 73 South Korea clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
Table 74 Thailand clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
Table 75 Thailand clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
Table 76 Thailand clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
Table 77 Thailand clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
Table 78 Latin America clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
Table 79 Latin America clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
Table 80 Latin America clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
Table 81 Latin America clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
Table 82 Brazil clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
Table 83 Brazil clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
Table 84 Brazil clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
Table 85 Brazil clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
Table 86 Mexico clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
Table 87 Mexico clinical trials supply chain management market, by type, 2018 - 2030 (USD Billion)
Table 88 Mexico clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
Table 89 Mexico clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
Table 90 MEA clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
Table 91 MEA clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
Table 92 MEA clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
Table 93 MEA clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
Table 94 South Africa clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
Table 95 South Africa clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
Table 96 South Africa clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
Table 97 South Africa clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
Table 98 Saudi Arabia clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
Table 99 Saudi Arabia clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
Table 100 Saudi Arabia clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
Table 101 Saudi Arabia clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
Table 102 UAE clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
Table 103 UAE clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
Table 104 UAE clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
Table 105 UAE clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
Table 106 Kuwait clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
Table 107 Kuwait clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
Table 108 Kuwait clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
Table 109 Kuwait clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market summary (Figures in USD Billion, 2022)
Fig. 8 Market trends & outlook
Fig. 9 Clinical trial supplies market: Market segmentation
Fig. 10 Clinical trial supplies market revenue, (USD Billion), 2018 - 2030
Fig. 11 Clinical trial supplies: Porter's analysis
Fig. 12 Clinical trial supplies: PESTEL analysis
Fig. 13 Clinical trial supplies market phase outlook key takeaways
Fig. 14 Clinical trial supplies market: Phase movement analysis
Fig. 15 Phase I market, 2018 - 2030 (USD Billion)
Fig. 16 Phase II market, 2018 - 2030 (USD Billion)
Fig. 17 Phase III market, 2018 - 2030 (USD Billion)
Fig. 18 Others market, 2018 - 2030 (USD Billion)
Fig. 19 Clinical trial supplies market product/service outlook key takeaways
Fig. 20 Clinical trial supplies market: Product/Service movement analysis
Fig. 21 Manufacturing market, 2018 - 2030 (USD Billion)
Fig. 22 Storage & distribution market, 2018 - 2030 (USD Billion)
Fig. 23 Cold chain-based storage & distribution market, 2018 - 2030 (USD Billion)
Fig. 24 Non-cold chain-based storage & distribution market, 2018 - 2030 (USD Billion)
Fig. 25 Supply chain management market, 2018 - 2030 (USD Billion)
Fig. 26 Clinical trial supplies market end-use outlook key takeaways
Fig. 27 Clinical trial supplies market: End-use movement analysis
Fig. 28 Pharmaceuticals market, 2018 - 2030 (USD Billion)
Fig. 29 Biologics market, 2018 - 2030 (USD Billion)
Fig. 30 Medical device market, 2018 - 2030 (USD Billion)
Fig. 31 Other end-use market, 2018 - 2030 (USD Billion)
Fig. 32 Clinical trial supplies market therapeutic use outlook key takeaways
Fig. 33 Clinical trial supplies market: Therapeutic Use movement analysis
Fig. 34 Oncology market, 2018 - 2030 (USD Billion)
Fig. 35 CNS market, 2018 - 2030 (USD Billion)
Fig. 36 Cardiovascular market, 2018 - 2030 (USD Billion)
Fig. 37 Infectious disease market, 2018 - 2030 (USD Billion)
Fig. 38 Metabolic disorders market, 2018 - 2030 (USD Billion)
Fig. 39 Other therapeutic use market, 2018 - 2030 (USD Billion)
Fig. 40 Regional marketplace: Key takeaways
Fig. 41 North America clinical trial supplies market, 2018 - 2030 (USD Billion)
Fig. 42 U.S. clinical trial supplies market, 2018 - 2030 (USD Billion)
Fig. 43 Canada clinical trial supplies market, 2018 - 2030 (USD Billion)
Fig. 44 Europe clinical trial supplies market, 2018 - 2030 (USD Billion)
Fig. 45 UK clinical trial supplies market, 2018 - 2030 (USD Billion)
Fig. 46 Germany clinical trial supplies market, 2018 - 2030 (USD Billion)
Fig. 47 France clinical trial supplies market, 2018 - 2030 (USD Billion)
Fig. 48 Italy clinical trial supplies market, 2018 - 2030 (USD Billion)
Fig. 49 Spain clinical trial supplies market, 2018 - 2030 (USD Billion)
Fig. 50 Denmark clinical trial supplies market, 2018 - 2030 (USD Billion)
Fig. 51 Sweden clinical trial supplies market, 2018 - 2030 (USD Billion)
Fig. 52 Norway clinical trial supplies market, 2018 - 2030 (USD Billion)
Fig. 53 Asia Pacific clinical trial supplies market, 2018 - 2030 (USD Billion)
Fig. 54 Japan clinical trial supplies market, 2018 - 2030 (USD Billion)
Fig. 55 China clinical trial supplies market, 2018 - 2030 (USD Billion)
Fig. 56 India clinical trial supplies market, 2018 - 2030 (USD Billion)
Fig. 57 Australia clinical trial supplies market, 2018 - 2030 (USD Billion)
Fig. 58 South Korea clinical trial supplies market, 2018 - 2030 (USD Billion)
Fig. 59 Thailand clinical trial supplies market, 2018 - 2030 (USD Billion)
Fig. 60 Latin America clinical trial supplies market, 2018 - 2030 (USD Billion)
Fig. 61 Brazil clinical trial supplies market, 2018 - 2030 (USD Billion)
Fig. 62 Mexico clinical trial supplies market, 2018 - 2030 (USD Billion)
Fig. 63 Argentina clinical trial supplies market, 2018 - 2030 (USD Billion)
Fig. 64 MEA clinical trial supplies market, 2018 - 2030 (USD Billion)
Fig. 65 South Africa clinical trial supplies market, 2018 - 2030 (USD Billion)
Fig. 66 Saudi Arabia clinical trial supplies market, 2018 - 2030 (USD Billion)
Fig. 67 UAE clinical trial supplies market, 2018 - 2030 (USD Billion)
Fig. 68 Kuwait clinical trial supplies market, 2018 - 2030 (USD Billion)

Product Code: GVR-1-68038-514-4

Clinical Trial Supplies Market Growth & Trends

The global clinical trial supplies market size is expected to reach USD 3.4 billion by 2030, expanding at 6.5% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. Increasing volume of clinical trial studies coupled with the growing complexity in conduction of these trials are some of the major factors driving the market growth.

Globally, an increase in the prevalence of chronic diseases and the rapidly aging population are expected to drive the growth of R&D of biologics, which is expected to further propel the demand for efficient clinical supplies and contribute to the growth of the clinical trial supplies industry. Furthermore, an increase in the demand for orphan drugs and high investment in the R&D of rare diseases are also expected to contribute toward the development of biologic drugs. Thus, owing to these factors, this segment is likely to witness significant growth during the forecast period.

For instance, in 2022, Novartis invested around USD 10 billion in research and development. It also secured 23 approvals in the European Union, Japan, China, and the U.S. for new drugs and rare diseases. The company is also conducting 44 ongoing phase III programs in India with 17 clinical programs running in rare diseases such as atypical hemolytic uremic syndrome (aHUS), Immune thrombocytopenic purpura (ITP), spinal muscular atrophy (SMA), and Lupus Nephritis.

Direct-to-Patients (DTP) is an upcoming segment in the distribution of clinical trial supplies, which is expected to be the future model of distribution. DTP is one of the emerging models that involves delivering drugs to patients directly to create patient-centric trials. This would facilitate fewer visits to the site and reduce the burden on participants. The COVID-19 outbreak has led to the increased adoption of such a model, to continue clinical trial studies with minimum disruption. In addition, patient retention and a diverse pool of patients worldwide are some of the notable reasons that can be attributed to the high adoption of this model.

Clinical Trial Supplies Market Report Highlights

Based on the clinical phase, the market is anticipated to be dominated by the Phase III trial segment with a 52.7% revenue share in 2022. The presence of a large number of molecules currently under Phase III makes it the primary factor responsible for this deduction
Among services, the storage, and distribution segment is anticipated to witness the fastest growth at a CAGR of 6.8% during the forecast period. The rise in global biologics pipeline and temperature-sensitive drugs is expected to increase the complexities related to the logistics of clinical trial supplies
Biologics are expected to witness the fastest growth at 6.7% CAGR during the forecast period owing to the increasing research in the field of genetics and biotechnology such as the development of nanoparticle-based drug delivery systems
In terms of therapeutic use, oncology dominated the market with a revenue share of 38.8% in 2022. According to the United Press International, hospitals in the U.S. are disposing of billions of cancer drug vials due to improper dosage, thereby indicating the need for appropriate supply management

Chapter 1. Research Methodology And Scope

1.1. Market Segmentation & Scope
- 1.1.1. Segment Definitions
- 1.1.2. Clinical Phase
- 1.1.3. Product & Services
- 1.1.4. End Use
- 1.1.5. Therapeutic Area
1.2. Regional Scope
1.3. Estimates And Forecast Timeline
1.4. Objectives
- 1.4.1. Objective - 1
- 1.4.2. Objective - 2
- 1.4.3. Objective - 3
1.5. Research Methodology
1.6. Information Procurement
- 1.6.1. Purchased Database
- 1.6.2. GVR's Internal Database
- 1.6.3. Secondary Sources
- 1.6.4. Primary Research
1.7. Information Or Data Analysis
- 1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
- 1.9.1. Commodity Flow Analysis
- 1.9.2. Parent Market Analysis
1.10. List Of Secondary Sources
1.11. List Of Abbreviations

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Clinical Trial Supplies Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
  - 3.2.1.1. Expansion of clinical trials sites
  - 3.2.1.2. Growing R&D in biologics and biosimilar
  - 3.2.1.3. Advancements in supply chain technology
- 3.2.2. Market Restraint Analysis
  - 3.2.2.1. Presence of stringent regulatory policies
  - 3.2.2.2. High Possibility of Counterfeiting Drugs
3.3. Clinical Trial Supplies Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.2. PESTEL Analysis
- 3.3.3. COVID-19 Impact Analysis

Chapter 4. Clinical Trial Supplies Market: Clinical Phase Estimates & Trend Analysis

4.1. Clinical Trial Supplies Market, By Clinical Phase: Segment Dashboard
4.2. Clinical Trial Supplies Market, By Clinical Phase: Movement Analysis
4.3. Clinical Trial Supplies Market Estimates & Forecasts, By Clinical Phase, 2018 - 2030
- 4.3.1. Phase I
  - 4.3.1.1. Phase I Clinical Trial Supplies Market, 2018 to 2030 (USD Billion)
- 4.3.2. Phase II
  - 4.3.2.1. Phase II Clinical Trial Supplies Market, 2018 to 2030 (USD Billion)
- 4.3.3. Phase III
  - 4.3.3.1. Phase III Clinical Trial Supplies Market, 2018 to 2030 (USD Billion)
- 4.3.4. Phase IV
  - 4.3.4.1. Phase IV Clinical Trial Supplies Market, 2018 to 2030 (USD Billion)
- 4.3.5. Others
  - 4.3.5.1. Others market, 2018 to 2030 (USD Billion)

Chapter 5. Clinical Trial Supplies Market: Product & Service Estimates & Trend Analysis

5.1. Clinical Trial Supplies Market, By Product & Service: Segment Dashboard
5.2. Clinical Trial Supplies Market, By Product & Service: Movement Analysis
5.3. Clinical Trial Supplies Market Estimates & Forecasts, By Product & Service, 2018 - 2030
- 5.3.1. Manufacturing
  - 5.3.1.1. Manufacturing Clinical Trial Supplies Market, 2018 to 2030 (USD Billion)
- 5.3.2. Storage & Distribution
  - 5.3.2.1. Storage & Distribution Clinical Trial Supplies Market, 2018 to 2030 (USD Billion)
- 5.3.3. Supply Chain Management
  - 5.3.3.1. Supply Chain Management Clinical Trial Supplies Market, 2018 to 2030 (USD Billion)

Chapter 6. Clinical Trial Supplies Market: Therapeutic Area Estimates & Trend Analysis

6.1. Clinical Trial Supplies Market, By Therapeutic Area: Segment Dashboard
6.2. Clinical Trial Supplies Market, By Therapeutic Area: Movement Analysis
6.3. Clinical Trial Supplies Market Estimates & Forecasts, By Therapeutic Area, 2018 - 2030
- 6.3.1. Oncology
  - 6.3.1.1. Oncology clinical trial supplies market 2018 to 2030 (USD Billion)
- 6.3.2. CNS
  - 6.3.2.1. CNS clinical trial supplies market 2018 to 2030 (USD Billion)
- 6.3.3. Cardiovascular
  - 6.3.3.1. Cardiovascular clinical trial supplies market 2018 to 2030 (USD Billion)
- 6.3.4. Infectious disease
  - 6.3.4.1. Infectious disease clinical trial supplies market 2018 to 2030 (USD Billion)
- 6.3.5. Metabolic disorders
  - 6.3.5.1. Metabolic Disorders Clinical Trial Supplies Market, 2018 to 2030 (USD Billion)
- 6.3.6. Others
  - 6.3.6.1. Others clinical trial supplies market 2018 to 2030 (USD Billion)

Chapter 7. Clinical Trial Supplies Market: End-use Estimates & Trend Analysis

7.1. Clinical Trial Supplies Market, By End-use: Segment Dashboard
7.2. Clinical Trial Supplies Market, By End-use: Movement Analysis
7.3. Clinical Trial Supplies Market Estimates & Forecasts, By End-use, 2018 - 2030
- 7.3.1. Pharmaceutical
  - 7.3.1.1. Pharmaceutical Clinical trial supplies market 2018 to 2030 (USD Billion)
- 7.3.2. Biologics
  - 7.3.2.1. Biologics clinical trial supplies market 2018 to 2030 (USD Billion)
- 7.3.3. Medical Devices
  - 7.3.3.1. Medical devices clinical trial supplies market 2018 to 2030 (USD Billion)
- 7.3.4. Others
  - 7.3.4.1. Others clinical trial supplies market 2018 to 2030 (USD Billion)

Chapter 8. Clinical Trial Supplies Market: Regional Estimates & Trend Analysis

8.1. Regional Market Share Analysis, 2022 & 2030
8.2. Regional Market Dashboard
8.3. Global Regional Market Snapshot
8.4. North America
- 8.4.1. Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Billion)
- 8.4.2. U.S.
  - 8.4.2.1. Key country dynamics
  - 8.4.2.2. Competitive scenario
  - 8.4.2.3. Regulatory framework
  - 8.4.2.4. U.S. market estimates and forecasts, 2018 - 2030
- 8.4.3. Canada
  - 8.4.3.1. Key country dynamics
  - 8.4.3.2. Competitive scenario
  - 8.4.3.3. Regulatory framework
  - 8.4.3.4. Canada market estimates and forecasts, 2018 - 2030
8.5. Europe
- 8.5.1. UK
  - 8.5.1.1. Key country dynamics
  - 8.5.1.2. Competitive scenario
  - 8.5.1.3. Regulatory framework
  - 8.5.1.4. UK market estimates and forecasts, 2018 - 2030
- 8.5.2. Germany
  - 8.5.2.1. Key country dynamics
  - 8.5.2.2. Competitive scenario
  - 8.5.2.3. Regulatory framework
  - 8.5.2.4. Germany market estimates and forecasts, 2018 - 2030
- 8.5.3. France
  - 8.5.3.1. Key country dynamics
  - 8.5.3.2. Competitive scenario
  - 8.5.3.3. Regulatory framework
  - 8.5.3.4. France market estimates and forecasts, 2018 - 2030
- 8.5.4. Italy
  - 8.5.4.1. Key country dynamics
  - 8.5.4.2. Competitive scenario
  - 8.5.4.3. Regulatory framework
  - 8.5.4.4. Italy market estimates and forecasts, 2018 - 2030
- 8.5.5. Spain
  - 8.5.5.1. Key country dynamics
  - 8.5.5.2. Competitive scenario
  - 8.5.5.3. Regulatory framework
  - 8.5.5.4. Spain market estimates and forecasts, 2018 - 2030
- 8.5.6. Denmark
  - 8.5.6.1. Key country dynamics
  - 8.5.6.2. Competitive scenario
  - 8.5.6.3. Regulatory framework
  - 8.5.6.4. Denmark market estimates and forecasts, 2018 - 2030
- 8.5.7. Sweden
  - 8.5.7.1. Key country dynamics
  - 8.5.7.2. Competitive scenario
  - 8.5.7.3. Regulatory framework
  - 8.5.7.4. Sweden market estimates and forecasts, 2018 - 2030
- 8.5.8. Norway
  - 8.5.8.1. Key country dynamics
  - 8.5.8.2. Competitive scenario
  - 8.5.8.3. Regulatory framework
  - 8.5.8.4. Norway market estimates and forecasts, 2018 - 2030
8.6. Asia Pacific
- 8.6.1. Japan
  - 8.6.1.1. Key country dynamics
  - 8.6.1.2. Competitive scenario
  - 8.6.1.3. Regulatory framework
  - 8.6.1.4. Japan market estimates and forecasts, 2018 - 2030
- 8.6.2. India
  - 8.6.2.1. Key country dynamics
  - 8.6.2.2. Competitive scenario
  - 8.6.2.3. Regulatory framework
  - 8.6.2.4. India market estimates and forecasts, 2018 - 2030
- 8.6.3. China
  - 8.6.3.1. Key country dynamics
  - 8.6.3.2. Competitive scenario
  - 8.6.3.3. Regulatory framework
  - 8.6.3.4. China market estimates and forecasts, 2018 - 2030
- 8.6.4. South Korea
  - 8.6.4.1. Key country dynamics
  - 8.6.4.2. Competitive scenario
  - 8.6.4.3. Regulatory framework
  - 8.6.4.4. South Korea market estimates and forecasts, 2018 - 2030
- 8.6.5. Australia
  - 8.6.5.1. Key country dynamics
  - 8.6.5.2. Competitive scenario
  - 8.6.5.3. Regulatory framework
  - 8.6.5.4. Australia market estimates and forecasts, 2018 - 2030
- 8.6.6. Thailand
  - 8.6.6.1. Key country dynamics
  - 8.6.6.2. Competitive scenario
  - 8.6.6.3. Regulatory framework
  - 8.6.6.4. Thailand market estimates and forecasts, 2018 - 2030
8.7. Latin America
- 8.7.1. Brazil
  - 8.7.1.1. Key country dynamics
  - 8.7.1.2. Competitive scenario
  - 8.7.1.3. Regulatory framework
  - 8.7.1.4. Brazil market estimates and forecasts, 2018 - 2030
- 8.7.2. Mexico
  - 8.7.2.1. Key country dynamics
  - 8.7.2.2. Competitive scenario
  - 8.7.2.3. Regulatory framework
  - 8.7.2.4. Mexico Market estimates and forecasts, 2018 - 2030
- 8.7.3. Argentina
  - 8.7.3.1. Key country dynamics
  - 8.7.3.2. Competitive scenario
  - 8.7.3.3. Regulatory framework
  - 8.7.3.4. Argentina market estimates and forecasts, 2018 - 2030
8.8. MEA
- 8.8.1. South Africa
  - 8.8.1.1. Key country dynamics
  - 8.8.1.2. Competitive scenario
  - 8.8.1.3. Regulatory framework
  - 8.8.1.4. South Africa market estimates and forecasts, 2018 - 2030
- 8.8.2. Saudi Arabia
  - 8.8.2.1. Key country dynamics
  - 8.8.2.2. Competitive scenario
  - 8.8.2.3. Regulatory framework
  - 8.8.2.4. Saudi Arabia market estimates and forecasts, 2018 - 2030
- 8.8.3. UAE
  - 8.8.3.1. Key country dynamics
  - 8.8.3.2. Competitive scenario
  - 8.8.3.3. Regulatory framework
  - 8.8.3.4. UAE market estimates and forecasts, 2018 - 2030
- 8.8.4. Kuwait
  - 8.8.4.1. Key country dynamics
  - 8.8.4.2. Competitive scenario
  - 8.8.4.3. Regulatory framework
  - 8.8.4.4. Kuwait market estimates and forecasts, 2018 - 2030

Chapter 9. Competitive Landscape

9.1. Market Participant Categorization
- 9.1.1. Innovators
- 9.1.2. Market Leaders
- 9.1.3. Emerging Players
- 9.1.4. Company Market Share Analysis, 2022
9.2. Company Profiles
- 9.2.1. Almac Group
  - 9.2.1.1. Company overview
  - 9.2.1.2. Financial performance
  - 9.2.1.3. Service benchmarking
  - 9.2.1.4. Strategic initiatives
- 9.2.2. Biocair
  - 9.2.2.1. Company overview
  - 9.2.2.2. Financial performance
  - 9.2.2.3. Service benchmarking
  - 9.2.2.4. Strategic initiatives
- 9.2.3. Catalent, Inc.
  - 9.2.3.1. Company overview
  - 9.2.3.2. Financial performance
  - 9.2.3.3. Service benchmarking
  - 9.2.3.4. Strategic initiatives
- 9.2.4. KLIFO
  - 9.2.4.1. Company overview
  - 9.2.4.2. Financial performance
  - 9.2.4.3. Service benchmarking
  - 9.2.4.4. Strategic initiatives
- 9.2.5. Movianto
  - 9.2.5.1. Company overview
  - 9.2.5.2. Financial performance
  - 9.2.5.3. Service benchmarking
  - 9.2.5.4. Strategic initiatives
- 9.2.6. PCI Pharma Services
  - 9.2.6.1. Company overview
  - 9.2.6.2. Financial performance
  - 9.2.6.3. Service benchmarking
  - 9.2.6.4. Strategic initiatives
- 9.2.7. Sharp Services, LLC
  - 9.2.7.1. Company overview
  - 9.2.7.2. Financial performance
  - 9.2.7.3. Service benchmarking
  - 9.2.7.4. Strategic initiatives
- 9.2.8. Thermo Fisher Scientific, Inc.
  - 9.2.8.1. Company overview
  - 9.2.8.2. Financial performance
  - 9.2.8.3. Service benchmarking
  - 9.2.8.4. Strategic initiatives
- 9.2.9. Marken
  - 9.2.9.1. Company overview
  - 9.2.9.2. Financial performance
  - 9.2.9.3. Service benchmarking
  - 9.2.9.4. Strategic initiatives
- 9.2.10. Paraxel International Corporation
  - 9.2.10.1. Company overview
  - 9.2.10.2. Financial performance
  - 9.2.10.3. Service benchmarking
  - 9.2.10.4. Strategic initiatives

臨床試験用品の市場規模、シェア、動向分析レポート：臨床フェーズ別、製品・サービス別、最終用途別、治療用途別、地域別、セグメント予測、2023年～2030年

Clinical Trial Supplies Market Size, Share & Trends Analysis Report By Clinical Phase (Phase I, Phase II, Phase III), By Product & Services, By End-Use, By Therapeutic Use, By Region, And Segment Forecasts, 2023 - 2030

臨床試験用品市場の成長と動向

臨床試験用品市場レポートハイライト

目次

第1章調査手法と範囲

第2章エグゼクティブサマリー

第3章臨床試験用品市場の変数、動向、範囲

第4章臨床試験用品市場：臨床フェーズの推定・動向分析

第5章臨床試験用品市場：製品とサービスの推定・動向分析

第6章臨床試験用品市場：治療領域の推定・動向分析

第7章臨床試験用品市場：最終使用の推定・動向分析

第8章臨床試験用品市場：地域推定・動向分析

第9章競合情勢

List of Tables

List of Figures

Clinical Trial Supplies Market Growth & Trends

Clinical Trial Supplies Market Report Highlights

Table of Contents

Chapter 1. Research Methodology And Scope

Chapter 2. Executive Summary

Chapter 3. Clinical Trial Supplies Market Variables, Trends & Scope

Chapter 4. Clinical Trial Supplies Market: Clinical Phase Estimates & Trend Analysis

Chapter 5. Clinical Trial Supplies Market: Product & Service Estimates & Trend Analysis

Chapter 6. Clinical Trial Supplies Market: Therapeutic Area Estimates & Trend Analysis

Chapter 7. Clinical Trial Supplies Market: End-use Estimates & Trend Analysis

Chapter 8. Clinical Trial Supplies Market: Regional Estimates & Trend Analysis

Chapter 9. Competitive Landscape

臨床試験用品の市場規模、シェア、動向分析レポート：臨床フェーズ別、製品・サービス別、最終用途別、治療用途別、地域別、セグメント予測、2023年～2030年

Clinical Trial Supplies Market Size, Share & Trends Analysis Report By Clinical Phase (Phase I, Phase II, Phase III), By Product & Services, By End-Use, By Therapeutic Use, By Region, And Segment Forecasts, 2023 - 2030

臨床試験用品市場の成長と動向

臨床試験用品市場レポートハイライト

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 臨床試験用品市場の変数、動向、範囲

第4章 臨床試験用品市場：臨床フェーズの推定・動向分析

第5章 臨床試験用品市場：製品とサービスの推定・動向分析

第6章 臨床試験用品市場：治療領域の推定・動向分析

第7章 臨床試験用品市場：最終使用の推定・動向分析

第8章 臨床試験用品市場：地域推定・動向分析

第9章 競合情勢

List of Tables

List of Figures

Clinical Trial Supplies Market Growth & Trends

Clinical Trial Supplies Market Report Highlights

Table of Contents

Chapter 1. Research Methodology And Scope

Chapter 2. Executive Summary

Chapter 3. Clinical Trial Supplies Market Variables, Trends & Scope

Chapter 4. Clinical Trial Supplies Market: Clinical Phase Estimates & Trend Analysis

Chapter 5. Clinical Trial Supplies Market: Product & Service Estimates & Trend Analysis

Chapter 6. Clinical Trial Supplies Market: Therapeutic Area Estimates & Trend Analysis

Chapter 7. Clinical Trial Supplies Market: End-use Estimates & Trend Analysis

Chapter 8. Clinical Trial Supplies Market: Regional Estimates & Trend Analysis

Chapter 9. Competitive Landscape

第1章調査手法と範囲

第2章エグゼクティブサマリー

第3章臨床試験用品市場の変数、動向、範囲

第4章臨床試験用品市場：臨床フェーズの推定・動向分析

第5章臨床試験用品市場：製品とサービスの推定・動向分析

第6章臨床試験用品市場：治療領域の推定・動向分析

第7章臨床試験用品市場：最終使用の推定・動向分析

第8章臨床試験用品市場：地域推定・動向分析

第9章競合情勢